Economic impact

The main lobby organisation for Europe’s chemical industry, CEFIC, has been keen to publicise a new study from the European Commission, a “Cumulative Cost Assessment” of the cost of regulation on Europe’s chemical industry. However, as the European Commission has pointed out, the study doesn’t consider economic or broader societal benefits of the legislation (such as [...]

A major US-based study has found that producing and using safer chemicals is good for business, and recommends that companies that are not already evaluating the potential of safer chemicals should do so. The study estimates that the market for safer chemicals has 24 times the growth potential of the worldwide conventional chemicals market , and that job creation in [...]

CHEM Trust was among the many participants in yesterday’s European Commission conference on hormone (or endocrine) disrupting chemicals (EDCs). The Commission’s Health Department (DG Santé) had organised the conference to discuss the next steps of an impact assessment on the potential socio-economic impacts of draft criteria to identify EDCs. Once finalised, these criteria will be applied in several EU [...]

New research, published today, finds that the costs across the EU of exposure to hormone disrupting chemicals could be over €150 billion annually in health care expenses and lost earning potential. Chemicals with hormone (or endocrine) disrupting properties (EDCs) are present in many everyday products and are frequently used as pesticides, but industry lobbying has delayed [...]

A new study, commissioned by Nordic governments and published today (press release here), finds that the damage to male reproductive health from exposure to hormone (or endocrine) disrupting chemicals is likely to cost many millions of euros every year in the EU. The study only looks at the costs of a small number of disorders of [...]